Supplementary Table 4. Relative Risk (95% Confidence Interval) of Carotid Atherosclerosis Progression According to Small Dense LDL Cholesterol Quartile and Dichotomized LDL Cholesterol in Participants with Intermediate or Low Cardiovascular Risk.
| Variables | No of participants | Plaque progression | Plaque incidence | Multi-territorial extent of new plaque | Total area of new plaque |
|---|---|---|---|---|---|
| LDLC < 130 mg/dL + sdLDLC < 33 mg/dL | 175 | Reference | Reference | Reference | Reference |
| LDLC < 130 mg/dL + sdLDLC 33–47 mg/dL | 88 | 1.28 (0.93–1.77) | 1.27 (0.89–1.82) | 1.31 (0.79–2.20) | 1.31 (0.79–2.20) |
| LDLC < 130 mg/dL + sdLDLC 48–62 mg/dL | 44 | 1.25 (0.81–1.93) | 1.44 (0.90–2.31) | 2.22 (1.17–4.18) | 2.12 (1.12–4.00) |
| LDLC < 130 mg/dL + sdLDLC ≥ 63 mg/dL | 20 | 2.05 (1.36–3.07) | 1.96 (1.15–3.34) | 3.46 (1.53–5.82) | 4.17 (1.83–5.52) |
| LDLC ≥ 130 mg/dL + sdLDLC < 33 mg/dL | 9 | 0.95 (0.26–3.48) | 0.57 (0.07–4.51) | 0.99 (0.17–5.93) | 1.01 (0.17–5.13) |
| LDLC ≥ 130 mg/dL + sdLDLC 33–47 mg/dL | 95 | 1.33 (0.89–2.00) | 1.34 (0.87–2.09) | 1.66 (0.84–3.25) | 1.74 (0.89–3.42) |
| LDLC ≥ 130 mg/dL + sdLDLC 48–62 mg/dL | 126 | 1.45 (1.04–2.02) | 1.46 (1.02–2.09) | 2.16 (1.22–3.81) | 1.87 (1.05–3.30) |
| LDLC ≥ 130 mg/dL + sdLDLC ≥ 63 mg/dL | 109 | 1.57 (1.15–2.14) | 1.40 (0.98–2.00) | 1.72 (1.01–2.95) | 1.76 (1.03–3.02) |
LDL, low-density lipoprotein; LDLC, low-density lipoprotein cholesterol; No, number; sdLDLC, small dense low-density lipoprotein cholesterol. Relative risk was calculated using a modified Poisson regression model after adjustment for known cardiovascular disease risk factors, lipid-lowering treatment, and large buoyant LDLC.